Serial Blood and Urine Monitoring Study in Kidney Transplant Recipients
About this study
There is a need to develop blood and/or urine tests that will help to detect early signs of rejection in people who have had kidney transplant. Researchers will examine blood, urine, and tissue samples and try to identify genetic markers for certain conditions like rejection, response to therapy, and scarring of the kidney. By studying gene patterns, researchers hope to be able to diagnose these conditions earlier and improve kidney survival.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Subjects undergoing primary or subsequent deceased-donor or living donor kidney transplantation.
- Subject and/or parent guardian must be able to understand and provide informed consent.
- Female subjects of childbearing potential must have a negative pregnancy test within 6 weeks of study entry.
- Need for combined organ transplantation with an extra-renal organ and/or islet.
- Recipient of previous non-renal solid organ and/or islet cell transplantation.
- Infection with HCV or HIV.
- Inability or unwillingness of a participant to give written informed consent or comply with study protocol.
- Any condition that, in the opinion of the investigator, would interfere with the participant's ability to comply with study requirements.
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.
|Mayo Clinic Location
Mayo Clinic principal investigator
Raymond Heilman, M.D.
Closed for enrollment